Characterization of lymphangiogenesis in various stages of idiopathic diffuse alveolar damage.
In pulmonary fibrosis, an abnormal healing process, is believed to be involved in the damage to lung tissue. This process has not been correlated with lymphangiogenesis, which has garnered current interest in relation to wound healing. The aim of the present study was to clarify the characteristics of lymphangiogenesis in pulmonary fibrosis associated with idiopathic diffuse alveolar damage. Formalin-fixed and paraffin-embedded lung tissues from 13 autopsy cases with idiopathic diffuse alveolar damage were used. Antibodies specific to CD34 and D2-40 were used to detect blood vessels and lymphatics, respectively, and immunohistochemical examinations and morphometry analyses were performed. The standardized density of capillaries was increased significantly in the exudative stage of diffuse alveolar damage, whereas that of the lymphatics remained unchanged. In the proliferative stage, new lymphatics emerged, primarily in the intra-alveolar fibrotic lesions where capillaries were absent. In the fibrotic stage, in which the lung was shrunken, as revealed by the elevated density of pulmonary arteries, the standardized density of capillaries was reduced significantly. The standardized area density of the interstitium was elevated in the proliferative stage and subsequently reduced in the fibrotic stage. Three-dimensional reconstruction of images revealed that some new lymphatics lacked connection to existing lymphatics. During the progression of diffuse alveolar damage, lymphangiogenesis occurs independent of capillary angiogenesis.
Yamashita
Masahiro
M
Department of Pathology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan. yamam@mail.tains.tohoku.ac.jp
Iwama
Noriyuki
N
Date
Fumiko
F
Chiba
Ryoji
R
Ebina
Masahito
M
Miki
Hiroshi
H
Yamauchi
Kohei
K
Sawai
Takashi
T
Nose
Masato
M
Sato
Shinobu
S
Takahashi
Tohru
T
Ono
Masao
M
D000368:Aged; D000911:Antibodies, Monoclonal / Q000378:metabolism; D058846:Antibodies, Monoclonal, Murine-Derived; D018952:Antigens, CD34 / Q000378:metabolism; D005260:Female; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000473:pathology*; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D042583:Lymphangiogenesis / Q000502:physiology*; D008297:Male; D018919:Neovascularization, Physiologic / Q000502:physiology; D011650:Pulmonary Alveoli / Q000098:blood supply / Q000473:pathology*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018952:Antigens, CD34; C500987:monoclonal antibody D2-40